Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02130791 · ClinicalTrials.gov registry record · NA
Phenotypic and Genotypic Markers of Performance Vulnerability to Sleep Loss
A NA study of Sleep Restriction Then Total Sleep Deprivation and Total Sleep Deprivation Then Sleep Restriction, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT02130791 is a NA study of Sleep Restriction Then Total Sleep Deprivation and Total Sleep Deprivation Then Sleep Restriction that has completed, run by University of Pennsylvania. The registered enrollment target is 170 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02130791, a NA study of Sleep Restriction Then Total Sleep Deprivation and Total Sleep Deprivation Then Sleep Restriction, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
Insufficient sleep is common, affecting 20-40% of adults, and resulting from sleep disorders, medical conditions, work demands, stress/emotional distress, and social/domestic responsibilities. It produces significant social, financial and health-related costs, and it has increasingly become a major public health concern as population studies worldwide have found that reduced sleep duration is associated with increased risks of obesity, morbidity, and mortality. It is well established that sleep loss causes fatigue and sleepiness, as well as errors and accidents that are due to its adverse neurobehavioral effects on alertness, mood, and cognitive functions. However, there are substantial, trait-like differences among people in the extent to which they experience such neurobehavioral deficits when sleep deprived. Common genetic variations involved in sleep-wake, circadian, and cognitive regulation may underlie these large inter-individual differences in neurobehavioral vulnerability to sleep deprivation, though it remains unclear whether different types of sleep deprivation involve the same phenotypic responses and same genotypic contributors. This project will be the first large-scale investigation of markers of differential cognitive vulnerability to both acute total sleep loss and chronic partial sleep loss. It will identify individuals who are at significant risk for fatigue and severe impairments from sleep loss. A total of 110 healthy adults will undergo a 13-day laboratory protocol to thoroughly characterize their cognitive, psychological and physiological responses to two of the most common forms of sleep loss--acute total sleep deprivation (1 night of sleep loss) and chronic partial sleep deprivation (5 nights of sleep limited to 4 hr). The findings from this study will represent a critical first step toward tailoring appropriate follow-up interventions for sleep loss and its symptomatic relief by finding predictors of at-risk individuals who should avoid sle
Conditions Studied
Interventions
- BEHAVIORAL Sleep
Study Locations (1)
Pennsylvania
- Unit for Experimental Psychiatry, Sleep and Chronobiology Laboratory - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2010-10 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02130791
The ClinicalTrials.gov registry entry for NCT02130791 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sleep Restriction Then Total Sleep Deprivation appearing as the primary indexed condition, and to 1 intervention - of which Sleep is the first listed.
NCT02130791 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02130791 about?
NCT02130791 is a clinical study titled "Phenotypic and Genotypic Markers of Performance Vulnerability to Sleep Loss". Insufficient sleep is common, affecting 20-40% of adults, and resulting from sleep disorders, medical conditions, work demands, stress/emotional distress, and social/domestic responsibilities. It produces significant social, financial and health-related costs, and it has increasingly become a major ...
What is the current status of trial NCT02130791?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2010-10. Estimated completion is 2015-11.
What conditions does trial NCT02130791 study?
This clinical trial studies the following conditions: Sleep Restriction Then Total Sleep Deprivation, Total Sleep Deprivation Then Sleep Restriction.
What interventions are being tested in trial NCT02130791?
The interventions under investigation include: Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT02130791?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02130791 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Sleep Restriction Then Total Sleep Deprivation
All registered trials for this condition
Total Sleep Deprivation Then Sleep Restriction
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.